EBV seronegativity should rule out MS, researchers suggest

neurodiem-image

The association between Epstein-Barr virus (EBV) and MS has been confirmed by a study in which 100% of patients with early MS were found to be seropositive.

The finding has led the researchers to suggest that EBV seronegativity in patients with suspected inflammatory CNS disease should rule out MS as a diagnosis.

In the late-breaking news session at ECTRIMS, Dr Klemens Ruprecht, from Charité-Universitätsmedizin Berlin, Germany, reported the study results. He noted that the strong link between MS and EBV infection has been well established in previous research.

From an epidemiological perspective, MS could be considered to be a rare complication of EBV infection, he said.

Want to read more?

Want to read more?

Log in or sign up to access all Neurodiem content.

Already have an account? Log In

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.